De Novo

DEN240067: KMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013)

FDA De Novo · cytocell limited · decided Sep 19, 2025

Key facts

De Novo number DEN240067
Device name KMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013)
Applicant cytocell limited
Product code SFS
Date received Nov 22, 2024
Decision date Sep 19, 2025
Decision granted (DENG)
FDA classification Class II
Review panel Pathology
FEI number 3002646096

At a glance

  • None Later 510(k)s citing this De Novo
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events
  • No Decision summary on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About De Novo classification requests

The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.

Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date:

Browse all De Novo classification requests